ASK REDCHAT ANYTHING ABOUT PMV PHARMACEUTICALS INC.
PMV Pharmaceuticals Inc. (NASDAQ: PMVP)
Listen to this Section
$1.21
+0.0250
(
+2.12% )
43.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Rezatapopt/ PC14586 (p53 reactivator)DetailsSolid tumor/s, Cancer |
Phase 2 |
| Rezatapopt/ PC14586 (p53 reactivator) + KEYTRUDADetailsSolid tumor/s, Cancer |
Failed |
| Rezatapopt/ PC14586 (p53 reactivator) +/- azacitidineDetailsCancer, Blood cancer, Acute myeloid leukemia |
Phase 1b |
Market Data
|
| Open |
$1.21 |
| Previous Close |
$1.18 |
| Volume |
43.0K |
| Market Cap |
$62.93M |
| Day Range |
$1.17 - $1.21 |
| 52 Week Range |
$0.96 - $1.88 |
| Shares Outstanding |
53.33M |
| Change % |
+2.12% |
| Net Change |
▲ 0.0250 |
| Insider Ownership |
-0.02% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Medicinal Chemicals and Botanical Products |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-1,128,753.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-11-13 |
Sale |
-198407.00 |
Mack David Henry |
| 2023-09-18 |
Sale |
-4104.00 |
Jalota Deepika |
| 2023-09-18 |
Sale |
-6291.00 |
Alland Leila |
| 2023-08-08 |
Sale |
-85500.00 |
Mack David Henry |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 10-q |
Quarterly Reports |
69 |
Nov 12, 2025 |
| 8-k |
8K-related |
11 |
Nov 12, 2025 |
| 4 |
Insider transactions |
1 |
Oct 29, 2025 |
| 4 |
Insider transactions |
1 |
Oct 27, 2025 |
| 4 |
Insider transactions |
1 |
Sep 12, 2025 |
| 8-k |
8K-related |
57 |
Sep 10, 2025 |
| 10-q |
Quarterly Reports |
69 |
Aug 07, 2025 |
| 8-k |
8K-related |
11 |
Aug 07, 2025 |
| 4 |
Insider transactions |
1 |
Jul 03, 2025 |
| 4 |
Insider transactions |
1 |
Jul 03, 2025 |